HK1057752A1 - N-phenyl-2-pyrimidine-amine derivatives - Google Patents
N-phenyl-2-pyrimidine-amine derivativesInfo
- Publication number
- HK1057752A1 HK1057752A1 HK03108645A HK03108645A HK1057752A1 HK 1057752 A1 HK1057752 A1 HK 1057752A1 HK 03108645 A HK03108645 A HK 03108645A HK 03108645 A HK03108645 A HK 03108645A HK 1057752 A1 HK1057752 A1 HK 1057752A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- pyrimidine
- phenyl
- amine derivatives
- preparation
- medicaments
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Liquid Crystal Substances (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0022438.6A GB0022438D0 (en) | 2000-09-13 | 2000-09-13 | Organic Compounds |
PCT/EP2001/010503 WO2002022597A1 (en) | 2000-09-13 | 2001-09-11 | N-phenyl-2-pyrimidine-amine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1057752A1 true HK1057752A1 (en) | 2004-04-16 |
Family
ID=9899367
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK03108645A HK1057752A1 (en) | 2000-09-13 | 2003-11-26 | N-phenyl-2-pyrimidine-amine derivatives |
Country Status (14)
Country | Link |
---|---|
US (3) | US7081532B2 (xx) |
EP (1) | EP1322634B1 (xx) |
JP (1) | JP2004509111A (xx) |
CN (2) | CN1872850A (xx) |
AT (1) | ATE452129T1 (xx) |
AU (1) | AU2002218167A1 (xx) |
BR (1) | BR0113838A (xx) |
CA (2) | CA2416274C (xx) |
DE (1) | DE60140814D1 (xx) |
ES (1) | ES2336891T3 (xx) |
GB (1) | GB0022438D0 (xx) |
HK (1) | HK1057752A1 (xx) |
PT (1) | PT1322634E (xx) |
WO (1) | WO2002022597A1 (xx) |
Families Citing this family (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0022438D0 (en) * | 2000-09-13 | 2000-11-01 | Novartis Ag | Organic Compounds |
EP1408978A4 (en) * | 2001-06-21 | 2005-07-13 | Ariad Pharma Inc | NOVEL PHENYLAMINO-PYRIMIDINES AND THEIR USE |
GB0201508D0 (en) * | 2002-01-23 | 2002-03-13 | Novartis Ag | Organic compounds |
ATE447560T1 (de) * | 2002-06-28 | 2009-11-15 | Nippon Shinyaku Co Ltd | Amidderivat |
CA2494061C (en) * | 2002-07-31 | 2011-06-14 | Wayne R. Danter | Protein tyrosine kinase inhibitors |
CA2439440A1 (en) | 2002-09-05 | 2004-03-05 | Emory University | Treatment of tuberous sclerosis associated neoplasms |
GB0222514D0 (en) | 2002-09-27 | 2002-11-06 | Novartis Ag | Organic compounds |
US7629347B2 (en) * | 2002-10-09 | 2009-12-08 | Critical Outcome Technologies, Inc. | Protein tyrosine kinase inhibitors |
AU2003232650A1 (en) * | 2003-05-06 | 2004-11-26 | Il Yang Pharm Co., Ltd. | N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof |
AU2003242988A1 (en) * | 2003-06-06 | 2005-01-04 | Adibhatla Kali Sathya Bhujanga Rao | Process for the preparation of the anti-cancer drug imatinib and its analogues |
MXPA05013349A (es) * | 2003-06-13 | 2006-03-09 | Novartis Ag | Derivados de 2-amino-pirimidina como inhibidores de quinasa raf. |
WO2005063720A1 (ja) * | 2003-12-25 | 2005-07-14 | Nippon Shinyaku Co., Ltd. | アミド誘導体及び医薬 |
CA2551529C (en) | 2003-12-25 | 2011-02-01 | Nippon Shinyaku Co., Ltd. | Amide derivative and medicine |
AR047530A1 (es) * | 2004-02-04 | 2006-01-25 | Novartis Ag | Formas de sal de 4-(4-metilpiperazin-1-ilmetil)-n-(4-metil-3-(4-piridin-3-il)pirimidin-2-ilamino)fenil)-benzamida |
WO2006017353A2 (en) * | 2004-07-13 | 2006-02-16 | GOVERNMENT OF THE UNITED STATES, as represented byTHE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Treatment of viral infections |
MX2007002819A (es) | 2004-09-09 | 2007-08-14 | Natco Pharma Ltd | Nuevos derivados de fenilaminopirimidina como inhibidores de bcl-abl cinasa. |
US8735415B2 (en) | 2004-09-09 | 2014-05-27 | Natco Pharma Limited | Acid addition salts of (3,5-Bis trifluoromethyl)-N-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2ylamino)-phenyl]-benzamide |
US7939541B2 (en) | 2004-09-09 | 2011-05-10 | Natco Pharma Limited | Intermediates and a process employing the intermediates for the preparation of (3-trifluoromethylsulfonyl)-N-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2ylamino)-phenyl]-benzamide |
CN1972917B (zh) * | 2004-12-31 | 2010-08-25 | 孙飘扬 | 氨基嘧啶类化合物及其盐和其制备方法与药物用途 |
CN1939910A (zh) * | 2004-12-31 | 2007-04-04 | 孙飘扬 | 氨基嘧啶类化合物及其盐和其制备方法与药物用途 |
WO2006136391A2 (en) * | 2005-06-23 | 2006-12-28 | Novartis Ag | Treatment of solid tumor disease with combinations comprising imatinib and an efflux pump inhibitor |
KR100674813B1 (ko) * | 2005-08-05 | 2007-01-29 | 일양약품주식회사 | N-페닐-2-피리미딘-아민 유도체 및 그의 제조방법 |
US7514447B2 (en) * | 2005-09-27 | 2009-04-07 | Irm Llc | Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors |
US7977348B2 (en) * | 2006-04-27 | 2011-07-12 | Sicor Inc. | Polymorphic forms of imatinib mesylate and processes for preparation of novel crystalline forms as well as amorphous and form α |
US8067421B2 (en) * | 2006-04-27 | 2011-11-29 | Sicor Inc. | Polymorphic forms of imatinib mesylate and processes for preparation of novel crystalline forms as well as amorphous and form α |
UA93548C2 (uk) | 2006-05-05 | 2011-02-25 | Айерем Елелсі | Сполуки та композиції як модулятори хеджхогівського сигнального шляху |
MX2009002336A (es) * | 2006-09-01 | 2009-03-20 | Teva Pharma | Composiciones de imatinib. |
EP2471529A3 (en) | 2006-09-05 | 2012-10-10 | Emory University | Kinase Inhibitors for Preventing or Treating Pathogen Infection and Method of Use Thereof |
KR20090061068A (ko) * | 2006-10-26 | 2009-06-15 | 시코르, 인크. | 이매티닙의 제조 방법 |
EP2009008A1 (en) | 2006-10-26 | 2008-12-31 | Sicor, Inc. | Imatinib base, and imatinib mesylate and processes for preparation thereof |
JP5571387B2 (ja) | 2007-01-11 | 2014-08-13 | クリティカル・アウトカム・テクノロジーズ・インコーポレイテッド | 癌の治療のための化合物および方法 |
MX2009011950A (es) * | 2007-05-04 | 2009-12-11 | Irm Llc | Derivados de pirimidina y composiciones como inhibidores de cinasa c-kit y pdgfr. |
US20090012296A1 (en) * | 2007-05-29 | 2009-01-08 | Alexandr Jegorov | Processes for the preparation of crystalline form beta of imatinib mesylate |
CA2689989A1 (en) | 2007-06-04 | 2008-12-11 | Avila Therapeutics, Inc. | Heterocyclic compounds and uses thereof |
ES2368876T3 (es) | 2007-08-22 | 2011-11-23 | Irm Llc | Derivados de 2-heteroarilaminopirimidina como inhibidores de cinasa. |
MX2010002004A (es) | 2007-08-22 | 2010-03-11 | Irm Llc | Compuestos de 5-(4-(halo-alcoxi)-fenil)-pirimidin-2-amina y composiciones con inhibidores de cinasa. |
MX2010003200A (es) * | 2007-09-25 | 2010-04-30 | Teva Pharma | Composiciones de imatibnib estables. |
WO2009079797A1 (en) * | 2007-12-26 | 2009-07-02 | Critical Outcome Technologies, Inc. | Compounds and method for treatment of cancer |
AU2009213153A1 (en) * | 2008-02-11 | 2009-08-20 | Institute Of Enzymology, Biological Research Center, Hungarian Academy Of Sciences | Compounds with MDR1-inverse activity |
LT2265607T (lt) * | 2008-02-15 | 2017-03-27 | Rigel Pharmaceuticals, Inc. | Pirimidin-2-amino junginiai ir jų panaudojimas kaip jak kinazių slopiklių |
US9273077B2 (en) | 2008-05-21 | 2016-03-01 | Ariad Pharmaceuticals, Inc. | Phosphorus derivatives as kinase inhibitors |
HUE035029T2 (en) | 2008-05-21 | 2018-03-28 | Ariad Pharma Inc | Kinase inhibitor phosphorus derivatives |
JP2011526292A (ja) * | 2008-06-27 | 2011-10-06 | インディアナ・ユニバーシティ・リサーチ・アンド・テクノロジー・コーポレーション | 神経線維腫および関連する腫瘍を抑制および/または治療する物質および方法 |
CA2730890C (en) | 2008-07-17 | 2018-05-15 | Critical Outcome Technologies Inc. | Thiosemicarbazone inhibitor compounds and cancer treatment methods |
CN101417995B (zh) * | 2008-11-21 | 2012-06-06 | 陈依军 | 苯氧基嘧啶衍生物及其制备方法和用途 |
US8178529B2 (en) | 2009-04-15 | 2012-05-15 | Astrazeneca Ab | Imidazole substituted pyrimidines |
US8530492B2 (en) * | 2009-04-17 | 2013-09-10 | Nektar Therapeutics | Oligomer-protein tyrosine kinase inhibitor conjugates |
WO2010120388A1 (en) | 2009-04-17 | 2010-10-21 | Nektar Therapeutics | Oligomer-protein tyrosine kinase inhibitor conjugates |
CA2999435A1 (en) | 2010-04-01 | 2011-10-06 | Critical Outcome Technologies Inc. | Compounds and method for treatment of hiv |
CN102212057B (zh) * | 2011-04-13 | 2013-11-27 | 合肥工业大学 | 一种羧酸类非甾体抗炎药衍生物及其制备方法和用途 |
JP5999177B2 (ja) | 2011-05-04 | 2016-09-28 | アリアド・ファーマシューティカルズ・インコーポレイテッド | Egfr発動性がんの細胞増殖阻害用化合物 |
CN102796110B (zh) * | 2011-05-23 | 2016-03-30 | 复旦大学 | 苯胺嘧啶化合物及其制备方法和用途 |
AU2013204563B2 (en) | 2012-05-05 | 2016-05-19 | Takeda Pharmaceutical Company Limited | Compounds for inhibiting cell proliferation in EGFR-driven cancers |
CN103044394A (zh) * | 2012-12-20 | 2013-04-17 | 北京理工大学 | 一种苯基氨基嘧啶衍生物及其制备方法和用途 |
CN103058935B (zh) * | 2013-01-15 | 2015-05-06 | 四川大学 | 一种嘧啶类化合物及其制备方法和用途 |
US9611283B1 (en) | 2013-04-10 | 2017-04-04 | Ariad Pharmaceuticals, Inc. | Methods for inhibiting cell proliferation in ALK-driven cancers |
CN105859683B (zh) * | 2016-04-11 | 2018-09-28 | 连云港恒运药业有限公司 | 伊马替尼的高纯度工业制备工艺 |
CN107805240A (zh) * | 2016-09-08 | 2018-03-16 | 中国科学院合肥物质科学研究院 | 一种新型的pdgfr激酶抑制剂及其用途 |
CN107652266A (zh) * | 2017-10-27 | 2018-02-02 | 上海应用技术大学 | 一种靶向酪氨酸激酶小分子抑制剂及其应用 |
EP3935057A4 (en) * | 2019-03-05 | 2023-03-01 | Hongyi & Associates LLC | COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES AND CANCER |
CN110078708B (zh) * | 2019-05-08 | 2020-12-11 | 东南大学 | Smo/Bcr-Abl双靶向抑制剂及其合成方法和应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW225528B (xx) * | 1992-04-03 | 1994-06-21 | Ciba Geigy Ag | |
US5521184A (en) * | 1992-04-03 | 1996-05-28 | Ciba-Geigy Corporation | Pyrimidine derivatives and processes for the preparation thereof |
GB9914258D0 (en) * | 1999-06-18 | 1999-08-18 | Celltech Therapeutics Ltd | Chemical compounds |
GB0022438D0 (en) * | 2000-09-13 | 2000-11-01 | Novartis Ag | Organic Compounds |
-
2000
- 2000-09-13 GB GBGB0022438.6A patent/GB0022438D0/en not_active Ceased
-
2001
- 2001-09-11 AT AT01984640T patent/ATE452129T1/de active
- 2001-09-11 CA CA2416274A patent/CA2416274C/en not_active Expired - Fee Related
- 2001-09-11 ES ES01984640T patent/ES2336891T3/es not_active Expired - Lifetime
- 2001-09-11 CN CNA2006101002584A patent/CN1872850A/zh active Pending
- 2001-09-11 AU AU2002218167A patent/AU2002218167A1/en not_active Abandoned
- 2001-09-11 WO PCT/EP2001/010503 patent/WO2002022597A1/en active Application Filing
- 2001-09-11 JP JP2002526850A patent/JP2004509111A/ja active Pending
- 2001-09-11 DE DE60140814T patent/DE60140814D1/de not_active Expired - Lifetime
- 2001-09-11 EP EP01984640A patent/EP1322634B1/en not_active Expired - Lifetime
- 2001-09-11 PT PT01984640T patent/PT1322634E/pt unknown
- 2001-09-11 BR BR0113838-3A patent/BR0113838A/pt not_active IP Right Cessation
- 2001-09-11 CN CNB018155391A patent/CN100406452C/zh not_active Expired - Fee Related
- 2001-09-11 US US10/363,841 patent/US7081532B2/en not_active Expired - Lifetime
- 2001-09-11 CA CA2687476A patent/CA2687476A1/en not_active Abandoned
-
2003
- 2003-11-26 HK HK03108645A patent/HK1057752A1/xx not_active IP Right Cessation
-
2006
- 2006-06-07 US US11/448,649 patent/US7312216B2/en not_active Expired - Fee Related
-
2007
- 2007-07-26 US US11/828,367 patent/US7329661B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ES2336891T3 (es) | 2010-04-19 |
BR0113838A (pt) | 2003-06-03 |
ATE452129T1 (de) | 2010-01-15 |
PT1322634E (pt) | 2010-02-22 |
EP1322634B1 (en) | 2009-12-16 |
WO2002022597A1 (en) | 2002-03-21 |
EP1322634A1 (en) | 2003-07-02 |
US7329661B2 (en) | 2008-02-12 |
CA2416274C (en) | 2011-01-04 |
US7081532B2 (en) | 2006-07-25 |
US20070265292A1 (en) | 2007-11-15 |
US7312216B2 (en) | 2007-12-25 |
JP2004509111A (ja) | 2004-03-25 |
DE60140814D1 (de) | 2010-01-28 |
CA2687476A1 (en) | 2002-03-21 |
GB0022438D0 (en) | 2000-11-01 |
AU2002218167A1 (en) | 2002-03-26 |
US20060223818A1 (en) | 2006-10-05 |
CN1525967A (zh) | 2004-09-01 |
CN1872850A (zh) | 2006-12-06 |
US20040102453A1 (en) | 2004-05-27 |
CA2416274A1 (en) | 2002-03-21 |
CN100406452C (zh) | 2008-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1057752A1 (en) | N-phenyl-2-pyrimidine-amine derivatives | |
MY139302A (en) | Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof | |
WO2003053368A3 (en) | Chalcone derivatives and their use to treat diseases | |
MY139303A (en) | Novel aromatic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof | |
MXPA04000577A (es) | Derivados de dolastatina 10. | |
ES2187300A1 (es) | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos. | |
WO2004060882A8 (en) | Cb 1/cb 2 receptor ligands and their use in the treatment of pain | |
HK1065483A1 (en) | 4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidine derivatives | |
EP1783126A3 (en) | N-oxides of N-phenyl-2-pyrimidine-amine derivatives | |
TW200510392A (en) | Chemical compounds | |
TNSN04203A1 (en) | Benzoxazinone-derived compounds, their preparation and use as medicaments | |
GB0112348D0 (en) | Compounds | |
MY135850A (en) | Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use | |
TW200505452A (en) | Chemical compounds | |
ATE233754T1 (de) | Diphenyl-piperidin derivate | |
MY140630A (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
TW200504029A (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
BG106155A (en) | Novel derivatives and analogues of galanthamin | |
TW200504030A (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
ITMI20042475A1 (it) | Uso di derivati tiazolidinonici come agenti terapeutici | |
TW200504051A (en) | Novel acridine derivatives and their use as medicaments | |
AU2001266019A1 (en) | 2-amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentanoic acid amide derivatives | |
PE20030236A1 (es) | Derivados de bencimidazol 1-aril-2-n,s- u o-sustituidos, obtencion de medicamentos y preparados farmaceuticos que contienen estos derivados | |
SG146685A1 (en) | Dihydroporphine derivatives, processes for their preparation, and pharmaceutical compositions containing them | |
WO2004108094A3 (en) | Sulfonamide-substituted chalcone derivatives and their use to treat diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20140911 |